Provention Bio
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Provention Bio's past years’ income statements indicate that its last revenue has increased compared to the previous period by 824% to $12,895,000. The net income raised on -$113,565,000 and profit margin reached -881%. Total operating expenses were $140,544,000.

Profit Margin

Provention Bio, Inc. (NASDAQ:PRVB): Profit margin
2017 0 -9.13M
2018 0 -26.47M
2019 0 -42.19M
2020 0 -98.58M
2021 1.39M -114.43M -8203.01%
2022 12.89M -113.56M -880.69%

PRVB Income Statement (2017 – 2022)

2022 2021 2020 2019 2018 2017
Revenue
Revenue
12.89M1.39M0000
Cost of revenue
512K00000
Gross profit
12.38M1.39M0000
Operating exp.
Research and development
75.80M69.62M66.36M36.35M22.64M7.68M
Selling and marketing
000000
Total operating expenses
140.54M116.97M99.68M44.37M26.81M9.13M
Operating income
-128.16M-115.57M-99.68M-44.37M-26.81M-9.13M
Other income (expenses), net
1.20M146K583K1.08M-520K6.50K
Income before tax
-126.95M-115.43M-99.10M-43.28M-26.66M-9.13M
Income tax expense
-13.39M-1M-523K-1.08M-187K-131.50K
Net income
-113.56M-114.43M-98.58M-42.19M-26.47M-9.13M
Earnings per share
Basic EPS
-1.52-1.81-1.88-1.04-1.18-0.27
Diluted EPS
-1.52-1.81-1.88-1.04-1.18-0.27
Data sourceData sourceData sourceData sourceData source